<--- Back to Details
First PageDocument Content
5-Hydroxytryptophan / Hydroxyarenes / Nootropics / Tryptamines / Assay / High-throughput screening / Bisphenol A / Endocrine disruptor / Piperonyl butoxide
Date: 2016-05-03 13:11:46
5-Hydroxytryptophan
Hydroxyarenes
Nootropics
Tryptamines
Assay
High-throughput screening
Bisphenol A
Endocrine disruptor
Piperonyl butoxide

Endocrine Policy Forum January 28, 2013 Docket Identification Number EPA-HQ-OPPDr. Sharlene Matten

Add to Reading List

Source URL: 191hmt1pr08amfq62276etw2.wpengine.netdna-cdn.com

Download Document from Source Website

File Size: 208,82 KB

Share Document on Facebook

Similar Documents

The range of total costs for the activities from test order receipt to submission of a response to EPA, including voluntary cancellation, agreement to perform all screens, or submission of OSRI for some or all of the scr

The range of total costs for the activities from test order receipt to submission of a response to EPA, including voluntary cancellation, agreement to perform all screens, or submission of OSRI for some or all of the scr

DocID: 1rtSD - View Document

Endocrine Policy Forum May 2, 2012 Jane Scott Smith EPA Office of Pesticide Programs

Endocrine Policy Forum May 2, 2012 Jane Scott Smith EPA Office of Pesticide Programs

DocID: 1r0Lx - View Document

Abstract  Two 26 and 32 year studies of rodent carcinogens revealed that less than half were monkey carcinogens. However, some 50% of all chemicals tested for carcinogenicity in rodents are positive in at least one exper

Abstract Two 26 and 32 year studies of rodent carcinogens revealed that less than half were monkey carcinogens. However, some 50% of all chemicals tested for carcinogenicity in rodents are positive in at least one exper

DocID: 1qDMN - View Document

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

DocID: 1qyYG - View Document

Microsoft Word - EPF letter to OIGdoc

Microsoft Word - EPF letter to OIGdoc

DocID: 1qm0t - View Document